The development and description of the comparison group in the Look AHEAD trial

Jacqueline Ann Wesche-Thobaben, Jacqueline Ann Wesche-Thobaben

Abstract

Background: Despite more lifestyle intervention trials, there is little published information on the development of the comparison group intervention. This article describes the comparison group intervention, termed Diabetes Support and Education Intervention and its development for the Action for HEAlth in Diabetes (Look AHEAD) trial. Look AHEAD, a randomized, controlled, multicenter trial, was designed to determine whether an Intensive Lifestyle Intervention to reduce weight and increase physical activity reduces cardiovascular morbidity and mortality in overweight volunteers with type 2 diabetes compared to the Diabetes Support and Education Intervention. The Diabetes Support and Education Committee was charged with developing the Diabetes Support and Education Intervention with the primary aim of participant retention.

Purpose: The objectives were to design the Diabetes Support and Education Intervention sessions, standardize delivery across the 16 clinics, review quality and protocol adherence and advise on staffing and funding.

Methods: Following a mandatory session on basic diabetes education, three optional sessions were offered on nutrition, physical activity, and support yearly for 4 years. For each session, guidelines, objectives, activities, and a resource list were created.

Conclusions: Participant evaluations were very positive with hands on experiences being the most valuable. Retention so far at years 1 and 4 has been excellent and only slightly lower in the Diabetes Support and Education Intervention arm. The comparison group plays an important role in the success of a clinical trial. Understanding the effort needed to develop and implement the comparison group intervention will facilitate its implementation in future lifestyle intervention trials, particularly multicenter trials. Retention rates may improve by developing the comparison intervention simultaneously with the lifestyle intervention.

Trial registration: ClinicalTrials.gov NCT00017953.

Figures

Figure 1
Figure 1
Look AHEAD Trial Timeline

References

    1. The Diabetes Prevention Program Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999 April; 22(4): 623–34
    1. Diabetes Prevention Program Research Group The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002 December; 25(12): 2165–71
    1. Mann H, Djulbegovic B. Choosing a control intervention for a randomised clinical trial. BMC Med Res Methodol 2003 April 22; 3–7
    1. Djulbegovic B, Cantor A, Clarke M. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials. Account Res 2003 October; 10(4): 301–15
    1. Ryan DH, Espeland MA, Foster GD, et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003 October; 24(5): 610–28
    1. The Look AHEAD group The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it Obesity (Silver Spring). 2006 May; 14(5): 737–52
    1. Doak CC, Doak LG, Root JH. Teaching patients with low literacy. 2nd. Lipincott Williams & Wilkins; 1996.
    1. Wadden TA, Butryn ML. Behavioral treatment of obesity. Endocrinol Metab Clin North Am 2003 December; 32(4): 981–1003 x
    1. Wadden TA, Crerand CE, Brock J. Behavioral treatment of obesity. Psychiatr Clin North Am 2005 March; 28(1): 151–70 ix
    1. Gold BC, Burke S, Pintauro S, et al. Weight loss on the web: A pilot study comparing a structured behavioral intervention to a commercial program. Obesity (Silver Spring) 2007 January; 15(1): 155–64
    1. Scheen AJ, Finer N, Hollander P, et al. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 2006 November 11; 368(9548): 1660–72
    1. Dansinger ML, Gleason JA, Griffith JL, et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for Weight Loss and Heart Disease Risk Reduction: A Randomized Trial. J Am Med Assoc 2005 January 5; 293(1): 43–53
    1. Mobley RY, Moy CS, Reynolds SM, et al. Time trends in personnel certification and turnover in the Collaborative Ocular Melanoma Study. Clin Trials 2004 August; 1(8): 377–386
    1. Parra-Medina D, Wilcox S, Wilson DK, et al. Heart Healthy and Ethnically Relevant (HHER) Lifestyle trial for improving diet and physical activity in underserved African American women. Contemp Clin Trials 2010 January; 31(1): 92–104
    1. Svetkey LP, Stevens VJ, Brantley PJ, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008 Mar 12; 299(10): 1139–48 PubMed PMID: 18334689
    1. Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA 2007 March 7; 297(9): 969–77
    1. Espeland M. Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals with Type 2 Diabetes: One-Year Results of the Look AHEAD Trial. Diabetes Care 2007 March 15
    1. The Look AHEAD Research Group Long term effects of lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes: four year results of the Look AHEAD Trial. Arch Intern Med 2010; 170(17): 1566–1575
    1. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403
    1. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–50
    1. Howard BV, Van Horn L, Hsia J, Manson JE, et al. Low-Fat Dietary Pattern and Risk of Cardiovascular Disease. The Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295: 655–666

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe